NZ513762A - Human suppressor of fused - Google Patents

Human suppressor of fused

Info

Publication number
NZ513762A
NZ513762A NZ513762A NZ51376200A NZ513762A NZ 513762 A NZ513762 A NZ 513762A NZ 513762 A NZ513762 A NZ 513762A NZ 51376200 A NZ51376200 A NZ 51376200A NZ 513762 A NZ513762 A NZ 513762A
Authority
NZ
New Zealand
Prior art keywords
hsu
polypeptide
cells
sequence
cell
Prior art date
Application number
NZ513762A
Other languages
English (en)
Inventor
Maximilien Murone
Arnon Rosenthal
Donna M Stone
William I Wood
Sauvage Frederic J De
Austin L Gurney
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of NZ513762A publication Critical patent/NZ513762A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Glass Compositions (AREA)
NZ513762A 1999-03-05 2000-03-02 Human suppressor of fused NZ513762A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12309099P 1999-03-05 1999-03-05
US13573699P 1999-05-25 1999-05-25

Publications (1)

Publication Number Publication Date
NZ513762A true NZ513762A (en) 2001-09-28

Family

ID=26821226

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ513762A NZ513762A (en) 1999-03-05 2000-03-02 Human suppressor of fused

Country Status (9)

Country Link
EP (1) EP1159421B8 (enExample)
JP (1) JP4659219B2 (enExample)
KR (1) KR100721484B1 (enExample)
AT (1) ATE447614T1 (enExample)
AU (1) AU779258B2 (enExample)
CA (1) CA2362963C (enExample)
DE (1) DE60043258D1 (enExample)
NZ (1) NZ513762A (enExample)
WO (1) WO2000052166A1 (enExample)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6448020B1 (en) * 1997-12-19 2002-09-10 Rune Toftgard Molecules associated with the human suppressor of fused gene

Also Published As

Publication number Publication date
AU3867000A (en) 2000-09-21
EP1159421B8 (en) 2010-02-17
JP2002537812A (ja) 2002-11-12
EP1159421A1 (en) 2001-12-05
AU779258B2 (en) 2005-01-13
DE60043258D1 (de) 2009-12-17
ATE447614T1 (de) 2009-11-15
KR100721484B1 (ko) 2007-05-23
WO2000052166A1 (en) 2000-09-08
CA2362963A1 (en) 2000-09-08
EP1159421B1 (en) 2009-11-04
JP4659219B2 (ja) 2011-03-30
CA2362963C (en) 2014-05-06
KR20010113036A (ko) 2001-12-24

Similar Documents

Publication Publication Date Title
AU2877999A (en) Human homolog of the drosophila protein "fused"
CA2373814A1 (en) Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis
IL205793A (en) Polymeric-2 Polymeric Polypeptide of Vertebrates Spotted to Heterologous Amino Acid Sequence
US7144996B1 (en) Nucleic acid encoding human suppressor of fused
AU779258B2 (en) Human suppressor of fused
US20020143164A1 (en) Ras activator nucleic acid molecules, polypeptides and methods of use
ZA200106937B (en) Human suppressor of fused.
US7381543B2 (en) TAB1 protein and DNA coding therefore
US8648174B2 (en) Ucp4
EP1135496B1 (en) Ucp5
US6348575B1 (en) Patched-2
US7342102B2 (en) Uncoupling protein 5 (UCP5)
JP2002533062A5 (enExample)
AU2004200576A1 (en) Human homolog of the drosophila protein "fused"

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 7 YEARS UNTIL 02 MAR 2020 BY THOMSON REUTERS

Effective date: 20130305

EXPY Patent expired